Angelika D Wahner

Summary

Affiliation: University of California
Country: USA

Publications

  1. pmc Glutathione S-transferase mu, omega, pi, and theta class variants and smoking in Parkinson's disease
    Angelika D Wahner
    Department of Epidemiology, UCLA School of Public Health, Los Angeles, CA 90095 1772, USA
    Neurosci Lett 413:274-8. 2007
  2. ncbi Inflammatory cytokine gene polymorphisms and increased risk of Parkinson disease
    Angelika D Wahner
    Department of Epidemiology, UCLA School of Public Health, University of California, Los Angeles, CA 90095 1772, USA
    Arch Neurol 64:836-40. 2007
  3. ncbi Nonsteroidal anti-inflammatory drugs may protect against Parkinson disease
    Angelika D Wahner
    Department of Epidemiology, UCLA School of Public Health, Box 951772, 650 Charles E Young Drive, Los Angeles, CA 90095 1772, USA
    Neurology 69:1836-42. 2007
  4. pmc Statin use and the risk of Parkinson disease
    Angelika D Wahner
    Department of Epidemiology, UCLA School of Public Health, 650 Charles E Young Drive, Los Angeles, CA 90095 1772, USA
    Neurology 70:1418-22. 2008
  5. pmc Gain-of-function haplotypes in the vesicular monoamine transporter promoter are protective for Parkinson disease in women
    Charles E Glatt
    Department of Psychiatry, Weill Medical College of Cornell University, New York, NY 10028, USA
    Hum Mol Genet 15:299-305. 2006

Detail Information

Publications5

  1. pmc Glutathione S-transferase mu, omega, pi, and theta class variants and smoking in Parkinson's disease
    Angelika D Wahner
    Department of Epidemiology, UCLA School of Public Health, Los Angeles, CA 90095 1772, USA
    Neurosci Lett 413:274-8. 2007
    ..54, 95% CI: 0.32-0.90). Results were similar when combining all races. These findings and the paucity of similar studies suggest a need for further inquiry into the association between GSTs, smoking, and PD risk...
  2. ncbi Inflammatory cytokine gene polymorphisms and increased risk of Parkinson disease
    Angelika D Wahner
    Department of Epidemiology, UCLA School of Public Health, University of California, Los Angeles, CA 90095 1772, USA
    Arch Neurol 64:836-40. 2007
    ....
  3. ncbi Nonsteroidal anti-inflammatory drugs may protect against Parkinson disease
    Angelika D Wahner
    Department of Epidemiology, UCLA School of Public Health, Box 951772, 650 Charles E Young Drive, Los Angeles, CA 90095 1772, USA
    Neurology 69:1836-42. 2007
    ....
  4. pmc Statin use and the risk of Parkinson disease
    Angelika D Wahner
    Department of Epidemiology, UCLA School of Public Health, 650 Charles E Young Drive, Los Angeles, CA 90095 1772, USA
    Neurology 70:1418-22. 2008
    ..To investigate associations between statin (3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor) use and Parkinson disease (PD)...
  5. pmc Gain-of-function haplotypes in the vesicular monoamine transporter promoter are protective for Parkinson disease in women
    Charles E Glatt
    Department of Psychiatry, Weill Medical College of Cornell University, New York, NY 10028, USA
    Hum Mol Genet 15:299-305. 2006
    ..This finding is consistent with the prediction that increased sequestration of dopamine in secretory vesicles by VMAT2 is protective for PD...